RECURRENT BREAST CANCER
Clinical trials for RECURRENT BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BREAST CANCER trials appear
Sign up with your email to follow new studies for RECURRENT BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer: which hormone treatment shrinks tumors best before surgery?
Disease control OngoingThis phase 3 study tests whether giving a combination of two hormone-blocking drugs (fulvestrant and anastrozole) or fulvestrant alone before surgery works better than the standard anastrozole alone for shrinking estrogen receptor-positive breast cancer in postmenopausal women. A…
Matched conditions: RECURRENT BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New PET scan may predict breast cancer drug success
Diagnosis OngoingThis small pilot study tested whether a special PET scan using a radioactive tracer can predict how well patients with advanced HER2-positive breast cancer respond to the drug ado-trastuzumab emtansine (T-DM1). Ten women with cancer that had spread to other parts of the body rece…
Matched conditions: RECURRENT BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 15, 2026 11:55 UTC